Concurrent detection of cognitive impairment and amyloid positivity with a multimodal machine learning-enabled digital cognitive assessment

Abstract Background Early identification of cognitive impairment and brain pathology associated with Alzheimer’s disease (AD) is essential to maximize benefits from lifestyle interventions and emerging pharmacologic disease-modifying treatments (DMT). Digital cognitive assessments (DCAs) can quickly...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Ali Jannati, Karl Thompson, Claudio Toro-Serey, Joyce Gomes-Osman, Russell E. Banks, Connor Higgins, John Showalter, David Bates, Sean Tobyne, Alvaro Pascual-Leone
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2025-12-01
Sarja:	Alzheimer’s Research & Therapy
Aiheet:	Alzheimer’s disease Mild cognitive impairment Dementia Digital cognitive assessment Machine learning Positron emission tomography
Linkit:	https://doi.org/10.1186/s13195-025-01913-5
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!